Firstly, there was no head-to-head CVOT directly comparing these antidiabetic drug classes
It is an investigational triple-receptor agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors pathways involved in glucose regulation, energy balance, and metabolic homeostasis
Medicines that may interact with Wegovy include: Insulin and some diabetes medicines Taking Wegovy with insulin or medicines that increase insulin levels, such as sulfonylureas, may increase the risk of low blood sugar (hypoglycaemia)
For instance, Candida albicans exhibits resistance via ERG3 deletion and upregulation of ERG5 , ERG6 , and ERG25 ( Yu et al., 2012
meningitidis triggers the formation of microvilli-like protrusions (Eugene et al., 2002) while N